Cite
HARVARD Citation
Sena, L. et al. (2021). Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer. Oncologist. pp. e270-e278. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sena, L. et al. (2021). Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer. Oncologist. pp. e270-e278. [Online].